By Kamal Choudhury Sept 3 (Reuters) – Shares of Ultragenyx Pharmaceutical plunged on Thursday after its neurodevelopmental disorder treatment failed a closely watched late-stage trial, dealing a major blow to one of its biggest growth bets. The drug, apazunersen, failed to meet both its main goal of
By Maria Cheng and Aditya Kalra OTTAWA/NEW DELHI, Sept 3 (Reuters) – The Canadian Food Inspection Agency is looking into whether an illegal operation in India that labelled chips and other food products with fake nutrition information and expiry dates represents a risk to the country’s imports. Indi
Sept 3 (Reuters) – Transgene shares surged 20% in early Paris trading on Thursday, after the French biotechnology company reported positive Phase 1 trial data on its vaccine candidate for head and neck cancer. Investors have rewarded encouraging data from other personalised cancer-vaccine programmes
Sept 3 (Reuters) – GSK subsidiary GlaxoSmithKline Intellectual Property (No. 4) Ltd will pay a unit of HUTCHMED (China) $110 million upfront for rights to an experimental drug for solid tumours, the Chinese drugmaker said on Thursday. Shares in Hong-Kong-listed HUTCHMED were up about 15% after the a
JAKARTA, Sept 3 (Reuters) – Nearly 800 Indonesians have fallen ill in separate incidents of food poisoning linked to the government’s free meals programme, a member of a parliamentary commission overseeing health said, including more than 500 students in East Java province this week. President Prabo
By Jasmeen Ara Islam Shaikh Sept 3 (Reuters) – Australia’s Regis Healthcare said on Thursday that an increase in the government’s funding rate for residential aged care would not keep pace with inflation across the sector and economy, sending its shares to a more than two-year low. The Department of
By Gabriel Araujo SAO PAULO, Sept 3 (Reuters) – Nestle will invest 2 billion reais ($392.73 million) in its nutrition and health division in Brazil through 2028, including 600 million reais for a new infant formula factory in Minas Gerais state, the company said on Thursday. • The nutrition and heal
By Jennifer Rigby, Ajeng Ulfiana, Stanley Widianto and Heru Asprihanto BOGOR, Indonesia, Sept 3 (Reuters) – Intan Permatasari’s mother simply couldn’t refuse her daughter’s pleas for food. By the time she was 4, Intan had outgrown all the kindergarten uniforms and had to wear home-sewn clothes to sc
Sept 2 (Reuters) – The U.S. Pentagon issued detailed guidance on Wednesday for a new, mandatory testosterone deficiency screening policy for active-duty and reserve service members age 30 and older, a follow-up to Defense Secretary Pete Hegseth’s July announcement. The guidance, which is effective i
By Christy Santhosh Sept 2 (Reuters) – Ultragenyx Pharmaceutical said on Wednesday its experimental drug for a rare genetic neurodevelopmental disorder did not meet the main goal in a late-stage trial, sending its shares down 45% in aftermarket trading. The drug, apazunersen, was tested as a treatme
ZURICH, Sept 2 (Reuters) – Novartis could cut about 130 jobs in Switzerland as it relocates laboratory activities and shuts down some production in Basel, the Swiss drugmaker said on Wednesday. The company said it plans to transfer laboratories for biological cell banks, analytical testing procedure
Leading U.S. medical groups are urging people to get updated flu and COVID-19 vaccinations this fall, banding together Wednesday to issue shot guidelines — and highlight the science behind them — saying they hope to ease confusion caused by the Trump administration’s changing advice. Flu vaccination
By Olivia Le Poidevin GENEVA, Sept 2 (Reuters) – The head of the World Health Organization on Wednesday said the Ebola response needs to be scaled up to tackle the outbreak in the Democratic Republic of Congo, with tracking the chains of transmission still posing a challenge. “Until every chain is f
By Gradel Muyisa and Ange Kasongo BENI, Democratic Republic of Congo, Sept 2 (Reuters) – Schools reopened this week in areas of Democratic Republic of Congo hardest hit by Ebola, after authorities decided the risk of transmission was outweighed by the risk of pupils struggling with remote learning,
Sept 2 (Reuters) – Dutch gene therapy developer uniQure said on Wednesday it had applied for U.S. approval of its experimental treatment for Huntington’s disease after the FDA reversed its earlier position on the drug, sending the company’s shares up 5% in premarket trading. Huntington’s disease is
Sept 2 (Reuters) – South Korea’s Alteogen said on Wednesday it has signed a deal with Novartis worth up to $3.22 billion, giving the Swiss drugmaker access to its technology to make injectable versions of intravenous drugs. Here are the details: • Drugmakers are increasingly developing under-the-ski
Sept 2 (Reuters) – Bayer said on Wednesday its Crop Science business had introduced two out of 10 planned new products with peak annual sales of at least €500 million ($579 million) each and mapped out further market launches. Holding an investor event for the division, the German group also said it
By Sahil Pandey Sept 2 (Reuters) – AI company Owkin said on Wednesday it has signed a licensing deal with Germany’s Boehringer Ingelheim, giving the drugmaker access to its AI research platform and patient data to speed up discovery of drugs for cancer and immunity-related diseases. The deal adds Bo
Sept 2 (Reuters) – Israeli drugmaker Teva Pharmaceutical Industries, said on Wednesday its experimental drug helped prevent gluten-related intestinal damage in adults with celiac disease, meeting the main goal of a mid-stage trial. U.S.-listed shares of the company were up nearly 3% in early trading
DUBLIN, Sept 2 (Reuters) – Ireland’s health service operator was fined a record amount for an Irish public body by the country’s data regulator for storing medical records in “profound disarray” in areas including a turf shed and a disused bathroom that in some cases were contaminated by animal drop
By Nqobile Dludla JOHANNESBURG, Sept 2 (Reuters) – South Africa’s Aspen Pharmacare reported a 22% rise in annual normalised earnings on Wednesday, helped by strong demand for obesity and diabetes treatment Mounjaro, which it distributes, and improving profitability in its manufacturing business. The
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays) By Nancy Lapid Sept 2 (Reuters) – We also report on a study that may have found a way to prevent liver damage caused by fatty liver diseases, which affect millions of people. GENET
DAKAR, Sept 2 (Reuters) – The number of deaths in Democratic Republic of Congo’s Ebola outbreak has surpassed 3,000, government data showed on Wednesday, as the country’s worst-ever epidemic continues to spread across its northeast. The outbreak, caused by the Bundibugyo species of Ebola, became the
PLYMOUTH, Mass. (AP) — A Massachusetts jury plans to deliberate for a fifth day Wednesday on whether Lindsay Clancy was criminally responsible when she strangled her three children in 2023, amid conflicting testimony about her postpregnancy mental health. What happens if they can’t reach a verdict?
JAKARTA, Sept 2 (Reuters) – More than 500 students in Indonesia’s East Java were hospitalised with food poisoning suspected to have been caused by free meals provided by the government, and an investigation is underway, national and regional officials said on Wednesday. President Prabowo Subianto la
Sept 2 (Reuters) – Australia’s competition regulator on Wednesday approved Kimberly-Clark’s proposed $40 billion takeover of Kenvue, on condition the company divests Kenvue’s Carefree and Stayfree period care brands in the country to address competition concerns. Here are the details: • The Australi
WASHINGTON (AP) — The U.S. Department of Justice filed a federal lawsuit Tuesday against the school system in Kansas City, Kansas, over its policies on transgender students. The lawsuit comes more than a year after the Education Department first said it was investigating four districts in Kansas fol
Sept 1 (Reuters) – Britain said on Tuesday it would provide more than £50 million ($67.56 million) in new funding to support efforts to contain an Ebola outbreak in the Democratic Republic of Congo, where confirmed cases have surpassed 6,000 in the country’s largest-ever epidemic. • Britain allocate
By Dietrich Knauth NEW YORK, September 1 (Reuters) – A U.S. federal jury sided with Reckitt Benckiser’s Mead Johnson on Monday in a test trial over claims the company’s Enfamil infant formula for preterm babies caused necrotizing enterocolitis (NEC), a dangerous bowel disease. The Illinois jury conc
BUNIA, Congo (AP) — A new academic year began Tuesday across Congo despite concerns by parents and teachers that the ongoing Ebola outbreak poses risks to children in the epicenter. The resumption of classes comes in the middle of the fastest-growing outbreak of the disease ever, with 2,950 people k
